Cypralis, a life sciences company focussed on the discovery of novel therapeutics based on modulation of peptidyl-prolyl isomerases (PPIases) has acquired a portfolio of cyclophilin inhibitor assets from SCYNEXIS Inc, a NASDAQ-listed company headquartered in New Jersey, USA.
Wed, 13/07/2016 - 15:00
Mon, 11/07/2016 - 16:00
Pearson Medical Technologies, a leader in pharmacy automation solutions, will showcase at RBC Cardinal 2016 in Chicago, IL from July 20-23 with XchangeLabs.
Wed, 22/06/2016 - 09:00
Edinburgh, UK, 22nd June 2016 / Sciad Newswire / Synpromics Ltd, the leading synthetic promoter company, is pleased to announce an extension to the original colla
Wed, 22/06/2016 - 08:30
Results reveal key differences between digital health and other life science companies.
Mon, 20/06/2016 - 12:00
Cambridge, UK, 20th June 2016 / Sciad Newswire / The UK’s first Bio-Hackathon takes place in Cambridge this week from
Thu, 09/06/2016 - 13:45
Advanced cell-line technology could reduce costs of vaccine production.
Wed, 25/05/2016 - 12:15
Berlin, Germany, 25th May 2016 / Sciad Newswire / The winner of the Start-up Battle, a pitching competition taking place at Labiotech’s conference Refresh
Wed, 25/05/2016 - 09:00
Selcia opens new state-of-the-art API radiolabelling laboratory.
Fri, 20/05/2016 - 10:30
San Francisco, CA, USA, 20th May 2016 / Sciad Newswire / Irish software company Qualio scored big in Silicon Valley last week when it took the stage at 500 Startu
Thu, 05/05/2016 - 09:00
Mercia has committed follow-on capital to Medherant Ltd. Medherant’s patch, known as the TEPI-patch®, is a thin, strong, easy-to-apply and easy-to-remove patch capable of delivering higher doses of drugs.